A detailed history of Rothschild Investment LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 235 shares of ADMA stock, worth $5,315. This represents 0.0% of its overall portfolio holdings.

Number of Shares
235
Previous 100 135.0%
Holding current value
$5,315
Previous $1.12 Million 320.21%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$11.21 - $20.03 $1,513 - $2,704
135 Added 135.0%
235 $4.7 Million
Q2 2024

Jul 30, 2024

BUY
$5.98 - $11.18 $598 - $1,118
100 New
100 $1.12 Million
Q1 2024

Jul 31, 2024

SELL
$4.4 - $6.74 $352 - $539
-80 Reduced 80.0%
20 $132,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $4.44B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.